$SYK

6 theses
bullish 50%neutral 0%bearish 50%
Avg return (1y)
—
Win rate (1y)
— (0 resolved)

Past performance does not predict future results. Informational only, not investment advice.

Recent theses

Prices as of Nov 19, 4:55 PM ET
$SYKSEC Form 4bearish
STRYKER RONDA E · STRYKER CORP · 10d ago1 prior · awaiting results
Sold 550,000 @ $325.32 avg · $178,924,731 · 2026-11-06

Form 4: STRYKER RONDA E sold SYK

STRYKER RONDA E (Director at STRYKER CORP) reported an open-market sale of 550,000 shares of SYK at an average $325.32, roughly $178,924,731, in a Form 4 filed 2026-11-09.

Now $313.08as of Nov 19, 4:55 PM ET
SYK $310.00 P · Dec 18
Finishes below $310.00 in 29 days
40%
▲ 3.3%
View filing on SEC.gov →
$SYKr/ValueInvestingDiscussionbullish
u/Subject-Dig-7489 · 62d agono track record yet
“decided to buy Stryker at 273”

Thoughts on Stryker? Should I buy it?

Author has decided to buy Stryker at $273, signaling a bullish conviction after careful consideration and community discussion.

At post $274.25Now $313.08+14.2% since postedas of Nov 19, 4:55 PM ET
1d—
3d-0.3%
1w-1.0%
1m+7.4%
3m—
6m—
1y—
original post →
$SYKSEC Form 4bearish
STRYKER RONDA E · STRYKER CORP · 91d ago1 prior · awaiting results
Sold 350,000 @ $336.50 avg · $117,776,128 · 2026-08-18

Form 4: STRYKER RONDA E sold SYK

STRYKER RONDA E (Director at STRYKER CORP) reported an open-market sale of 350,000 shares of SYK at an average $336.50, roughly $117,776,128, in a Form 4 filed 2026-08-20.

At post $327.70Now $313.08-4.5% since postedas of Nov 19, 4:55 PM ET
1d+0.5%
3d+0.5%
1w-2.0%
1m-16.3%
3m—
6m—
1y—
View filing on SEC.gov →
$SYKSEC Form 4bearish
King Debra · See Remarks at STRYKER CORP · 93d agono track record yet
Sold 826 @ $336.30 avg · $277,787 · 2026-08-18

Form 4: King Debra sold SYK

King Debra (See Remarks at STRYKER CORP) reported an open-market sale of 826 shares of SYK at an average $336.30, roughly $277,787, in a Form 4 filed 2026-08-18.

At post $331.37Now $313.08-5.5% since postedas of Nov 19, 4:55 PM ET
1d+2.6%
3d-0.6%
1w-0.6%
1m-15.7%
3m-7.4%
6m—
1y—
View filing on SEC.gov →
$SYKr/ValueInvestingStock Analysisbullish
u/dat1976 · 116d ago4 prior · 50% at 3mo

Need suggestion on buying US stocks

Stryker is a highest-quality medical device business positioned to benefit from aging populations and robotic surgery adoption, with pricing power, sticky hospital relationships, and consistent acquisition-driven earnings growth.

At post $336.74Now $313.08-7.0% since postedas of Nov 19, 4:55 PM ET
1d+2.9%
3d+3.4%
1w+1.3%
1m-2.1%
3m-8.8%
6m—
1y—
original post →
$SYKr/ValueInvestingStock Analysisbullish
u/Away_Definition5829 · 121d ago22 prior · 31% at 3mo

15 Investment write-ups to look at

Surgical robotics market leader with an unbroken 32-year dividend streak, trading below its historical average post-cyberattack. High net debt of $12.3bn is a counterargument.

At post $309.24Now $313.08+1.2% since postedas of Nov 19, 4:55 PM ET
1d+3.1%
3d+6.8%
1w+13.9%
1m+6.5%
3m-1.6%
6m—
1y—
original post →

End of results.